Galactosylation of rat natural scaffold for MSC differentiation into hepatocyte-like cells: A comparative analysis of 2D vs. 3D cell culture techniques.
Cell differentiation
Galactosyl
Hepatocytes
Scaffolds
Stem cells
Journal
Biochemistry and biophysics reports
ISSN: 2405-5808
Titre abrégé: Biochem Biophys Rep
Pays: Netherlands
ID NLM: 101660999
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
27
04
2023
revised:
05
06
2023
accepted:
21
06
2023
medline:
21
8
2023
pubmed:
21
8
2023
entrez:
21
8
2023
Statut:
epublish
Résumé
The liver plays a crucial role in drug detoxification, and the main source of liver transplants is brain-dead patients. However, the demand for transplants exceeds the available supply, leading to controversies in selecting suitable candidates for acute liver diseases. This research aimed to differentiate mesenchymal stem cells (MSCs) into hepatocyte-like cells using galactosylated rat natural scaffolds and comparing 2-D and 3-D cell culture methods. The study involved isolating and culturing Wharton's jelly cells from the umbilical cord, examining surface markers and adipogenic differentiation potential of MSCs, and culturing mesenchymal cells on galactosylated scaffolds. The growth and proliferation of stem cells on the scaffolds were evaluated using the MTT test, and urea synthesis was measured in different culture environments. Changes in gene expression were analyzed using real-time PCR. Flow cytometry results confirmed the presence of specific surface antigens on MSCs, indicating their identity, while the absence of a specific antigen indicated their differentiation into adipocytes. The MTT test revealed higher cell attachment to galactosylated scaffolds compared to the control groups. Urea secretion was observed in differentiated cells, with the highest levels in cells cultured on galactosylated scaffolds. Gene expression analysis showed differential expression patterns for OCT-4, HNF1, ALB, AFP, and CYP genes under different conditions. The findings indicated that hepatocyte-like cells derived from 3D cultures on galactosylated scaffolds exhibited superior characteristics compared to cells in other culture conditions. These cells demonstrated enhanced proliferation, stability, and urea secretion ability. The study also supported the differentiation potential of MSCs derived from Wharton's jelly umbilical cord into liver-like cells.
Identifiants
pubmed: 37601454
doi: 10.1016/j.bbrep.2023.101503
pii: S2405-5808(23)00084-5
pmc: PMC10439353
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101503Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Tissue Eng Part A. 2014 Jan;20(1-2):313-23
pubmed: 24004192
Anesthesiology. 1993 Aug;79(2):340-6
pubmed: 8342843
Int J Cancer. 2007 Apr 1;120(7):1598-602
pubmed: 17205510
Sci Rep. 2016 Nov 29;6:37427
pubmed: 27897167
J Biol Chem. 2002 Nov 15;277(46):43799-808
pubmed: 12228247
Nature. 2014 Sep 4;513(7516):110-4
pubmed: 25043045
J Hematother. 1992 Summer;1(2):115-29
pubmed: 1285404
J Lab Autom. 2015 Jun;20(3):216-50
pubmed: 25617027
Biomaterials. 2015 Feb;40:72-9
pubmed: 25433603
Science. 2005 Nov 18;310(5751):1139-43
pubmed: 16293750
Hepatology. 2002 Jul;36(1):22-9
pubmed: 12085345
Drugs. 1984 Jun;27(6):528-47
pubmed: 6376061
Cell. 2008 Feb 22;132(4):598-611
pubmed: 18295578
Orthopedics. 2010 Jul 13;33(7):511
pubmed: 20608620
Cancer Res. 1991 May 15;51(10):2611-20
pubmed: 1708696
Bull Exp Biol Med. 2005 Jul;140(1):138-43
pubmed: 16254640
Chem Biol Drug Des. 2015 Mar;85(3):268-79
pubmed: 25059576
Acta Biomater. 2014 Jan;10(1):183-93
pubmed: 24055455
Tissue Eng Part A. 2011 Oct;17(19-20):2435-43
pubmed: 21563860
Stem Cells. 2007 Nov;25(11):2739-49
pubmed: 17656645
Biotechnol Adv. 2009 Jul-Aug;27(4):334-9
pubmed: 19232387
J Bone Joint Surg Am. 2006 Dec;88(12):2673-86
pubmed: 17142418
ASAIO J. 2006 May-Jun;52(3):321-7
pubmed: 16760723
Int J Dev Biol. 2006;50(7):645-52
pubmed: 16892178
Stem Cell Rev Rep. 2011 Mar;7(1):103-18
pubmed: 20182823
Biofabrication. 2015 Sep 10;7(3):031001
pubmed: 26355538
Tissue Eng Part A. 2011 Feb;17(3-4):361-70
pubmed: 20799907
Biomaterials. 2012 Oct;33(29):7028-38
pubmed: 22789723
Transl Res. 2009 Sep;154(3):122-32
pubmed: 19665688
J Cell Physiol. 2007 Nov;213(2):341-7
pubmed: 17620285
Anat Rec (Hoboken). 2014 Jan;297(1):51-64
pubmed: 24293290
Carcinogenesis. 2005 Feb;26(2):495-502
pubmed: 15513931
Biotechnol Lett. 2014 May;36(5):1095-106
pubmed: 24563289
J Biol Chem. 2005 Jul 1;280(26):24731-7
pubmed: 15860457
Lancet. 2008 Dec 13;372(9655):2023-30
pubmed: 19022496
Am J Physiol Gastrointest Liver Physiol. 2004 Nov;287(5):G1086-99
pubmed: 14715527
Arch Toxicol. 2014 May;88(5):1083-95
pubmed: 24599296
Sci Rep. 2016 May 04;6:25187
pubmed: 27143246
Stem Cells Dev. 2016 Dec 15;25(24):1898-1908
pubmed: 27676103
Biomed Mater. 2012 Oct;7(5):055005
pubmed: 22832766
Hepatology. 2010 Feb;51(2):595-602
pubmed: 20014114
Biomaterials. 1990 Nov;11(9):659-65
pubmed: 2090300
Tissue Eng Part C Methods. 2010 Jun;16(3):525-32
pubmed: 19702513
J R Soc Interface. 2006 Oct 22;3(10):589-601
pubmed: 16971328
Biochemistry. 1981 Nov 10;20(23):6665-72
pubmed: 6171301
J Biomed Mater Res. 1990 Jul;24(7):901-11
pubmed: 2398077
Ann Acad Med Singap. 2001 Mar;30(2):183-91
pubmed: 11379417
Stem Cells. 2004;22(5):649-58
pubmed: 15342929
Biotechnol Adv. 2014 Mar-Apr;32(2):504-13
pubmed: 24440487
Toxicol Res (Camb). 2016 Jun 1;5(4):1053-1065
pubmed: 27746894
Stem Cells Dev. 2004 Aug;13(4):436-48
pubmed: 15345137
Differentiation. 2008 Dec;76(10):1057-67
pubmed: 18557762